Connection

Christopher Mcmahan to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Christopher Mcmahan has written about Clinical Trials, Phase II as Topic.
Christopher Mcmahan
Connection Strength
0.039
Clinical Trials, Phase II as Topic
  1. Study design with staggered sampling times for evaluating sustained unresponsiveness to peanut sublingual immunotherapy. Stat Med. 2018 11 30; 37(27):3944-3958.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.